# The Role of Serum Adipokines in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer

> **NCT04598984** · — · UNKNOWN · sponsor: **Istanbul Training and Research Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Rectal Cancer Stage III

## Interventions

- **DIAGNOSTIC_TEST:** serum adipokines

## Key facts

- **NCT ID:** NCT04598984
- **Lead sponsor:** Istanbul Training and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04598984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04598984, "The Role of Serum Adipokines in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04598984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*